Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+7.43%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$7.23B
AUM Growth
+$403M
(+5.9%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
11.76%
Holding
2,092
New
496
Increased
452
Reduced
416
Closed
523
Top Buys
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$177M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$79.3M |
| 3 |
Exxon Mobil
XOM
|
+$64M |
| 4 |
NVIDIA
NVDA
|
+$58.2M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$40.2M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$284M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$248M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$151M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$81.9M |
| 5 |
VMW
VMware, Inc
VMW
|
+$78.2M |
Sector Composition
| 1 | Technology | 20.63% |
| 2 | Industrials | 12.87% |
| 3 | Financials | 11.51% |
| 4 | Healthcare | 11.22% |
| 5 | Consumer Discretionary | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Ventyx Biosciences
VTYX
$171M
| $95.3K | ﹤0.01% |
38,578
+32,613
| +547% | +$80.6K |
|
|
NSTG
1377
DELISTED
NanoString Technologies, Inc.
NSTG
| $88.7K | ﹤0.01% |
118,495
-3,297
| -3% | -$2.47K |
|
1378
Seres Therapeutics
MCRB
$153M
| $86.8K | ﹤0.01% |
3,099
-1,259
| -29% | -$35.3K |
|
1379
VinFast Auto
VFS
$7.65B
| $83.7K | ﹤0.01% |
10,000
-11,121
| -53% | -$93.1K |
|
1380
Bausch Health
BHC
$2.69B
| $83.6K | ﹤0.01% |
10,423
-6,752
| -39% | -$54.2K |
|
1381
Cato Corp
CATO
$90M
| $80.8K | ﹤0.01% |
11,312
-4,438
| -28% | -$31.7K |
|
|
CLYM
1382
Climb Bio, Inc. Common Stock
CLYM
$163M
| $79.6K | ﹤0.01% |
29,490
-214
| -0.7% | -$578 |
|
1383
Lexicon Pharmaceuticals
LXRX
$403M
| $72.1K | ﹤0.01% |
47,101
| – | – |
|
1384
Q32 Bio
QTTB
$22.4M
| $70.3K | ﹤0.01% |
6,424
| – | – |
|
1385
CytomX Therapeutics
CTMX
$351M
| $69.3K | ﹤0.01% |
44,730
| – | – |
|
|
TVRD
1386
Tvardi Therapeutics, Inc. Common Stock
TVRD
$309M
| $69.2K | ﹤0.01% |
2,587
| – | – |
|
1387
Inovio Pharmaceuticals
INO
$143M
| $68.8K | ﹤0.01% |
11,235
-7,600
| -40% | -$46.5K |
|
1388
Rayonier Advanced Materials
RYAM
$409M
| $66.8K | ﹤0.01% |
+16,492
| New | +$66.8K |
|
|
GAN
1389
DELISTED
GAN Ltd
GAN
| $63.9K | ﹤0.01% |
40,436
| – | – |
|
1390
Emergent Biosolutions
EBS
$434M
| $58.7K | ﹤0.01% |
24,464
+2,081
| +9% | +$4.99K |
|
|
AXDX
1391
DELISTED
Accelerate Diagnostics
AXDX
| $55.3K | ﹤0.01% |
14,114
| – | – |
|
1392
CureVac
CVAC
$1.22B
| $51.7K | ﹤0.01% |
+12,282
| New | +$51.7K |
|
|
CURO
1393
DELISTED
CURO Group Holdings Corp.
CURO
| $50K | ﹤0.01% |
62,536
| – | – |
|
1394
WideOpenWest
WOW
$440M
| $48.9K | ﹤0.01% |
12,068
-113,766
| -90% | -$461K |
|
1395
Latham Group
SWIM
$937M
| $47.4K | ﹤0.01% |
+18,014
| New | +$47.4K |
|
1396
FibroGen
FGEN
$46.5M
| $42.7K | ﹤0.01% |
1,928
| – | – |
|
1397
Gossamer Bio
GOSS
$748M
| $42.4K | ﹤0.01% |
46,464
| – | – |
|
1398
Gaotu Techedu
GOTU
$884M
| $40K | ﹤0.01% |
11,059
| – | – |
|
|
EMKR
1399
DELISTED
Emcore Corp
EMKR
| $38K | ﹤0.01% |
7,779
| – | – |
|
1400
Aclaris Therapeutics
ACRS
$224M
| $34.8K | ﹤0.01% |
33,183
| – | – |
|